Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Xếp hạng trong cổ phiếu #492
Operating globally, Becton, Dickinson and Company (BD) is a prominent... Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.
Giá cổ phiếu
$183.43
Vốn hóa thị trường
$50.54B
Thay đổi (1 ngày)
2.13%
Thay đổi (1 năm)
29.20%
Quốc gia
US
Giao dịch Becton, Dickinson and Company (BDX)

Danh mục

Doanh thu của Becton, Dickinson and Company (BDX)
Doanh thu vào Jun 2026 TTM: $20.84B
Theo các báo cáo tài chính gần đây của Becton, Dickinson and Company, doanh thu hiện tại của công ty (TTM) là $20.84B. Trong năm 2024, công ty đạt doanh thu $20.18B tăng so với doanh thu năm 2023, là $19.37B. Doanh thu là tổng số tiền công ty tạo ra từ việc bán hàng hóa hoặc dịch vụ. Không giống như lợi nhuận, doanh thu không trừ chi phí.
Lịch sử doanh thu của Becton, Dickinson and Company từ 2000 đến 2026
Doanh thu vào cuối mỗi năm
Năm Doanh thu Thay đổi
2026 (TTM) $20.84B -4.58%
2025 $21.84B 8.23%
2024 $20.18B 4.16%
2023 $19.37B 2.66%
2022 $18.87B -1.36%
2021 $19.13B 19.02%
2020 $16.07B -7.03%
2019 $17.29B 8.18%
2018 $15.98B 32.17%
2017 $12.09B -3.12%
2016 $12.48B 21.41%
2015 $10.28B 21.74%
2014 $8.45B 4.87%
2013 $8.05B 4.49%
2012 $7.71B 1.64%
2011 $7.58B 6.45%
2010 $7.12B 1.97%
2009 $6.99B -1.25%
2008 $7.07B 11.25%
2007 $6.36B 10.83%
2006 $5.74B 5.97%
2005 $5.41B 9.73%
2004 $4.93B 10.56%
2003 $4.46B 12.70%
2002 $3.96B 5.49%
2001 $3.75B 3.76%
2000 $3.62B 0.00%
Doanh thu của các công ty hoặc đối thủ tương tự
Công ty Doanh thu Chênh lệch doanh thu Quốc gia
$11.03B -47.05%
US
$34.74B 66.69%
FR
- -
JP
- -
CH
- -
US